
Juanita Dionne Jackson
Examiner (ID: 392)
| Most Active Art Unit | 2853 |
| Art Unit(s) | 2853, 2108 |
| Total Applications | 2176 |
| Issued Applications | 2044 |
| Pending Applications | 21 |
| Abandoned Applications | 123 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5974388
[patent_doc_number] => 20110152898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'TISSUE ENGINEERED CONSTRUCTS'
[patent_app_type] => utility
[patent_app_number] => 12/991643
[patent_app_country] => US
[patent_app_date] => 2009-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15171
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20110152898.pdf
[firstpage_image] =>[orig_patent_app_number] => 12991643
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/991643 | TISSUE ENGINEERED CONSTRUCTS | May 7, 2009 | Abandoned |
Array
(
[id] => 6367480
[patent_doc_number] => 20100074849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'ORGANIC ACID FREE EFFERVESCENT FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 12/425458
[patent_app_country] => US
[patent_app_date] => 2009-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2469
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20100074849.pdf
[firstpage_image] =>[orig_patent_app_number] => 12425458
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/425458 | Organic acid free effervescent formulation | Apr 16, 2009 | Issued |
Array
(
[id] => 5952610
[patent_doc_number] => 20110033536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => '24-HOUR SUSTAINED-RELEASE METOCLOPRAMIDE'
[patent_app_type] => utility
[patent_app_number] => 12/935187
[patent_app_country] => US
[patent_app_date] => 2009-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3198
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20110033536.pdf
[firstpage_image] =>[orig_patent_app_number] => 12935187
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/935187 | 24-HOUR SUSTAINED-RELEASE METOCLOPRAMIDE | Mar 26, 2009 | Abandoned |
| 12/381399 | Method and composition for employing an electrolyzed saline solution exhibiting putative mechanism of action for cancer therapy | Mar 10, 2009 | Abandoned |
Array
(
[id] => 6007140
[patent_doc_number] => 20110059171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'ORAL GALENIC FORMULATION INCLUDING KETOROLAC AND B-COMPLEX VITAMINS, IN WHICH VITAMIN B6 IS IN AN OUTER LAYER SEPARATED FROM THE REST OF THE ACTIVE PRINCIPLES'
[patent_app_type] => utility
[patent_app_number] => 12/921317
[patent_app_country] => US
[patent_app_date] => 2009-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5499
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059171.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921317
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921317 | ORAL GALENIC FORMULATION INCLUDING KETOROLAC AND B-COMPLEX VITAMINS, IN WHICH VITAMIN B6 IS IN AN OUTER LAYER SEPARATED FROM THE REST OF THE ACTIVE PRINCIPLES | Mar 3, 2009 | Abandoned |
Array
(
[id] => 8227203
[patent_doc_number] => 20120141392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'METHODS OF MODULATING THE ACTIVITY OF THE MC1 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 13/203674
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40863
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13203674
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/203674 | METHODS OF MODULATING THE ACTIVITY OF THE MC1 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR | Feb 26, 2009 | Abandoned |
Array
(
[id] => 5538639
[patent_doc_number] => 20090220444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'Antiperspirant and Deodorant Compositions with Improved Protective Action'
[patent_app_type] => utility
[patent_app_number] => 12/394558
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19843
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220444.pdf
[firstpage_image] =>[orig_patent_app_number] => 12394558
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/394558 | Antiperspirant and Deodorant Compositions with Improved Protective Action | Feb 26, 2009 | Abandoned |
Array
(
[id] => 5532966
[patent_doc_number] => 20090232754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'ENHANCED PHOTOSTABILITY OF SUNCARE COMPOSITIONS CONTAINING AVOBENZONE'
[patent_app_type] => utility
[patent_app_number] => 12/392465
[patent_app_country] => US
[patent_app_date] => 2009-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5338
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20090232754.pdf
[firstpage_image] =>[orig_patent_app_number] => 12392465
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/392465 | ENHANCED PHOTOSTABILITY OF SUNCARE COMPOSITIONS CONTAINING AVOBENZONE | Feb 24, 2009 | Abandoned |
Array
(
[id] => 6466564
[patent_doc_number] => 20100040557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'Double-layered zaleplon- contained tablet'
[patent_app_type] => utility
[patent_app_number] => 12/379314
[patent_app_country] => US
[patent_app_date] => 2009-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3664
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20100040557.pdf
[firstpage_image] =>[orig_patent_app_number] => 12379314
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/379314 | Double-layered zaleplon- contained tablet | Feb 18, 2009 | Abandoned |
Array
(
[id] => 5538813
[patent_doc_number] => 20090220618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'PHARMACEUTICAL FORMULATIONS COMPRISING POLYANIONIC MATERIALS AND SOURCE OF HYDROGEN PEROXIDE'
[patent_app_type] => utility
[patent_app_number] => 12/370706
[patent_app_country] => US
[patent_app_date] => 2009-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11662
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220618.pdf
[firstpage_image] =>[orig_patent_app_number] => 12370706
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/370706 | PHARMACEUTICAL FORMULATIONS COMPRISING POLYANIONIC MATERIALS AND SOURCE OF HYDROGEN PEROXIDE | Feb 12, 2009 | Abandoned |
Array
(
[id] => 6443301
[patent_doc_number] => 20100104727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'Methods For Preserving Endogenous TGF-Beta'
[patent_app_type] => utility
[patent_app_number] => 12/370374
[patent_app_country] => US
[patent_app_date] => 2009-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12828
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20100104727.pdf
[firstpage_image] =>[orig_patent_app_number] => 12370374
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/370374 | Methods for preserving endogenous TGF-β | Feb 11, 2009 | Issued |
Array
(
[id] => 6517948
[patent_doc_number] => 20100202985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'SUNSCREEN COMPOSITIONS INCLUDING PARTICULATE SUNSCREEN ACTIVES THAT EXHIBIT BOOSTING OF SUN PROTECTION FACTOR'
[patent_app_type] => utility
[patent_app_number] => 12/369514
[patent_app_country] => US
[patent_app_date] => 2009-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4126
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20100202985.pdf
[firstpage_image] =>[orig_patent_app_number] => 12369514
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/369514 | SUNSCREEN COMPOSITIONS INCLUDING PARTICULATE SUNSCREEN ACTIVES THAT EXHIBIT BOOSTING OF SUN PROTECTION FACTOR | Feb 10, 2009 | Abandoned |
Array
(
[id] => 6579638
[patent_doc_number] => 20100290992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'NANOPARTICLE NUCLEIC ACID BINDING COMPOUND CONJUGATES FORMING I-MOTIFS'
[patent_app_type] => utility
[patent_app_number] => 12/367827
[patent_app_country] => US
[patent_app_date] => 2009-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 17552
[patent_no_of_claims] => 83
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0290/20100290992.pdf
[firstpage_image] =>[orig_patent_app_number] => 12367827
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/367827 | NANOPARTICLE NUCLEIC ACID BINDING COMPOUND CONJUGATES FORMING I-MOTIFS | Feb 8, 2009 | Abandoned |
Array
(
[id] => 5952511
[patent_doc_number] => 20110033506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'COMBINATION DOSAGE FORM OF LOW-DOSE MODAFINIL AND LOW-DOSE SILDENAFIL'
[patent_app_type] => utility
[patent_app_number] => 12/865727
[patent_app_country] => US
[patent_app_date] => 2009-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10236
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20110033506.pdf
[firstpage_image] =>[orig_patent_app_number] => 12865727
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/865727 | COMBINATION DOSAGE FORM OF LOW-DOSE MODAFINIL AND LOW-DOSE SILDENAFIL | Feb 7, 2009 | Abandoned |
Array
(
[id] => 5928981
[patent_doc_number] => 20110038940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'PULVERULENT COMPOSITION AND A PROCESS FOR PREPARING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/865927
[patent_app_country] => US
[patent_app_date] => 2009-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8741
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20110038940.pdf
[firstpage_image] =>[orig_patent_app_number] => 12865927
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/865927 | PULVERULENT COMPOSITION AND A PROCESS FOR PREPARING THE SAME | Feb 5, 2009 | Abandoned |
Array
(
[id] => 5526756
[patent_doc_number] => 20090196833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'COMPOSITIONS COMPRISING TOPICAL DPD INHIBITORS AND METHODS OF USING SAME IN THE TREATMENT OF HAND-FOOT SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 12/367367
[patent_app_country] => US
[patent_app_date] => 2009-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10579
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20090196833.pdf
[firstpage_image] =>[orig_patent_app_number] => 12367367
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/367367 | COMPOSITIONS COMPRISING TOPICAL DPD INHIBITORS AND METHODS OF USING SAME IN THE TREATMENT OF HAND-FOOT SYNDROME | Feb 5, 2009 | Abandoned |
Array
(
[id] => 6321132
[patent_doc_number] => 20100196514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'CALCIUM SILICATE-BASED COMPOSITE CEMENT AND METHODS FOR THE PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 12/364278
[patent_app_country] => US
[patent_app_date] => 2009-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6602
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196514.pdf
[firstpage_image] =>[orig_patent_app_number] => 12364278
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/364278 | CALCIUM SILICATE-BASED COMPOSITE CEMENT AND METHODS FOR THE PREPARATION | Feb 1, 2009 | Abandoned |
Array
(
[id] => 6195601
[patent_doc_number] => 20110027356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'Combination of Oral Medicaments Bonded by a Wrapping'
[patent_app_type] => utility
[patent_app_number] => 12/864397
[patent_app_country] => US
[patent_app_date] => 2009-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7075
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20110027356.pdf
[firstpage_image] =>[orig_patent_app_number] => 12864397
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/864397 | Combination of Oral Medicaments Bonded by a Wrapping | Jan 25, 2009 | Abandoned |
Array
(
[id] => 6600170
[patent_doc_number] => 20100322864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'TELEMETRY THROUGH REMOTE DETECTION OF NMR-ACTIVE PARTICLES'
[patent_app_type] => utility
[patent_app_number] => 12/812069
[patent_app_country] => US
[patent_app_date] => 2009-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8830
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0322/20100322864.pdf
[firstpage_image] =>[orig_patent_app_number] => 12812069
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/812069 | TELEMETRY THROUGH REMOTE DETECTION OF NMR-ACTIVE PARTICLES | Jan 8, 2009 | Abandoned |
Array
(
[id] => 9059406
[patent_doc_number] => 08545841
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-01
[patent_title] => 'Methods and compositions for the treatment of cancers and pathogenic infections'
[patent_app_type] => utility
[patent_app_number] => 12/811646
[patent_app_country] => US
[patent_app_date] => 2009-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 17
[patent_no_of_words] => 4172
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12811646
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/811646 | Methods and compositions for the treatment of cancers and pathogenic infections | Jan 4, 2009 | Issued |